• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞学特征和核评分:RAS 或 BRAF K601E 突变的不确定甲状腺结节术前细针穿刺中的诊断工具?

Cytological features and nuclear scores: Diagnostic tools in preoperative fine needle aspiration of indeterminate thyroid nodules with RAS or BRAF K601E mutations?

机构信息

Centre de Biologie et Pathologie Sud, Centre Hospitalier Lyon Sud, Pierre Bénite, France.

Biochemistry and Molecular Biology Department, Centre Hospitalier Lyon Sud, Pierre Bénite, France.

出版信息

Cytopathology. 2021 Jan;32(1):37-44. doi: 10.1111/cyt.12904. Epub 2020 Oct 12.

DOI:10.1111/cyt.12904
PMID:32803788
Abstract

INTRODUCTION

The cytological diagnosis of follicular-patterned thyroid lesions is challenging, especially since the World Health Organisation classification has recognised non-invasive follicular thyroid neoplasm with papillary-like features. These entities are often classified as indeterminate on cytology. Molecular testing has been proposed to help classify indeterminate nodules. RAS and K601E BRAF mutations are mostly encountered in follicular-patterned lesions, but their diagnostic value is not well established. Nuclear scores have also been proposed to help classify indeterminate lesions.

OBJECTIVE

To investigate the correlation between cytological features and histology and to assess nuclear scores in a series of indeterminate RAS or BRAF K601E positive thyroid nodules.

METHODS

The cytological parameters of 69 indeterminate RAS or BRAF K601E-positive thyroid nodules were evaluated. The Strickland and Maletta scores and a new nuclear score were assessed. Diagnosis of malignant, benign or indolent neoplasms was confirmed in each case by histology. Malignant and indolent nodules were considered surgical nodules, and adenomas non-surgical nodule.

RESULTS

Surgical nodules were associated with the presence of ground glass nuclei (P = .001), grooves (P < .001) or irregular nuclear membranes (P = .01) on cytology. Nuclear scores were more often ≥2 in surgical nodules compared to benign ones (P < .001), with high sensitivity, but a low negative predictive value.

CONCLUSIONS

Analysis of nuclear features is useful to distinguish non-surgical from surgical nodules in indeterminate FNAs. Although nuclear scores are not ideal rule-out tests for indeterminate RAS or BRAF K601E positive nodules, they seem useful to screen non-molecular tested or non-mutated indeterminate FNAs. This work shows that meticulous analysis of nuclear features on cytological specimens can be useful to distinguish non-surgical nodules (adenoma) from surgical nodules in indeterminate FNAs. Although nuclear scores are not rule-out tests for indeterminate RAS or BRAF K601E positive nodules, they are useful in screening non-molecular tested or non-mutated indeterminate FNAs for surgery.

摘要

简介

滤泡性甲状腺病变的细胞学诊断具有挑战性,特别是世界卫生组织(World Health Organisation)分类已经认识到具有乳头状特征的非浸润性滤泡性甲状腺肿瘤。这些实体通常在细胞学上被归类为不确定。分子检测已被提议用于帮助分类不确定的结节。RAS 和 K601E BRAF 突变主要见于滤泡性病变,但它们的诊断价值尚未得到充分确立。核评分也被提议用于帮助分类不确定的病变。

目的

研究一系列不确定的 RAS 或 BRAF K601E 阳性甲状腺结节中细胞学特征与组织学的相关性,并评估核评分。

方法

评估了 69 个不确定的 RAS 或 BRAF K601E 阳性甲状腺结节的细胞学参数。评估了 Strickland 和 Maletta 评分以及新的核评分。通过组织学确认每个病例的恶性、良性或惰性肿瘤的诊断。恶性和惰性结节被认为是手术性结节,腺瘤是非手术性结节。

结果

细胞学上存在毛玻璃核(P =.001)、沟(P <.001)或不规则核膜(P =.01)与手术性结节相关。与良性结节相比,手术性结节的核评分更常≥2(P <.001),具有较高的敏感性,但阴性预测值较低。

结论

在不确定的细针抽吸活检(FNAs)中,分析核特征有助于区分非手术性和手术性结节。虽然核评分不是不确定的 RAS 或 BRAF K601E 阳性结节的理想排除试验,但它们似乎有助于筛选非分子检测或非突变的不确定 FNAs。这项工作表明,在不确定的 FNAs 中,对细胞学标本核特征的细致分析有助于区分非手术性结节(腺瘤)和手术性结节。虽然核评分不是不确定的 RAS 或 BRAF K601E 阳性结节的排除试验,但它们在筛选非分子检测或非突变的不确定 FNAs 以进行手术方面是有用的。

相似文献

1
Cytological features and nuclear scores: Diagnostic tools in preoperative fine needle aspiration of indeterminate thyroid nodules with RAS or BRAF K601E mutations?细胞学特征和核评分:RAS 或 BRAF K601E 突变的不确定甲状腺结节术前细针穿刺中的诊断工具?
Cytopathology. 2021 Jan;32(1):37-44. doi: 10.1111/cyt.12904. Epub 2020 Oct 12.
2
Preoperative Role of RAS or BRAF K601E in the Guidance of Surgery for Indeterminate Thyroid Nodules.术前 RAS 或 BRAF K601E 检测在甲状腺结节手术指导中的作用
World J Surg. 2020 Jul;44(7):2264-2271. doi: 10.1007/s00268-020-05487-1.
3
RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.不确定甲状腺结节中的RAS突变可预测甲状腺乳头状癌的滤泡变体。
Clin Endocrinol (Oxf). 2015 May;82(5):760-6. doi: 10.1111/cen.12579. Epub 2014 Nov 28.
4
The mutational analysis in the diagnostic work-up of thyroid nodules: the real impact in a center with large experience in thyroid cytopathology.甲状腺结节诊断工作中的基因突变分析:在一个具有丰富甲状腺细胞学经验的中心的实际影响。
J Endocrinol Invest. 2019 Feb;42(2):157-166. doi: 10.1007/s40618-018-0895-z. Epub 2018 Apr 27.
5
Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy.对甲状腺细针穿刺活检(FNA)结果为不明确的样本进行BRAF、RAS和端粒酶逆转录酶(TERT)的分子检测可提高诊断准确性。
Cytopathology. 2017 Dec;28(6):482-487. doi: 10.1111/cyt.12493. Epub 2017 Nov 2.
6
Semiquantitative assessment of cytomorphologic features can predict mutation status of thyroid nodules with indeterminate cytologic diagnosis.半定量评估细胞学形态特征可预测细胞学诊断不确定的甲状腺结节的突变状态。
Hum Pathol. 2019 Nov;93:81-89. doi: 10.1016/j.humpath.2019.08.010. Epub 2019 Aug 19.
7
Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.提出具有乳头状核特征的非浸润性滤泡性甲状腺肿瘤(NIFTP)的细胞学诊断:不典型和可疑结节的回顾性分析。
Cancer Cytopathol. 2018 Feb;126(2):86-93. doi: 10.1002/cncy.21922. Epub 2017 Sep 15.
8
BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.甲状腺不典型细胞学标本中 BRAF 突变的检测:甲状腺乳头状癌的潜在细胞学、分子和病理学特征。
Cancer Cytopathol. 2013 Apr;121(4):197-205. doi: 10.1002/cncy.21229. Epub 2012 Aug 7.
9
Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.激光捕获显微切割是甲状腺滤泡性病变术前分子筛查中的一种有价值的工具:一项机构经验。
Cytopathology. 2015 Oct;26(5):288-96. doi: 10.1111/cyt.12226. Epub 2014 Dec 8.
10
Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.临床实践中使用ThyroSeq v2.1对甲状腺结节进行二代测序靶向检测
Del Med J. 2016 Dec;88(12):366-372.

引用本文的文献

1
A Comprehensive Approach to the Thyroid Bethesda Category III (AUS) in the Transition Zone Between 2nd Edition and 3rd Edition of The Bethesda System for Reporting Thyroid Cytopathology: Subcategorization, Nuclear Scoring, and More.《贝塞斯达系统报告甲状腺细胞病理学》第 2 版和第 3 版之间过渡区域甲状腺贝塞斯达类别 III(AUS)的综合方法:细分、核评分及更多。
Endocr Pathol. 2024 Mar;35(1):51-76. doi: 10.1007/s12022-024-09797-1. Epub 2024 Jan 27.
2
Molecular Testing for Thyroid Nodules of Indeterminate Cytology: A Health Technology Assessment.甲状腺细胞学不确定结节的分子检测:一项卫生技术评估。
Ont Health Technol Assess Ser. 2022 Apr 1;22(2):1-111. eCollection 2022.